<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:department>Biomedical Sciences</gtr:department><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A7A13E3D-3470-4D74-9C16-64C5146A5A40"><gtr:id>A7A13E3D-3470-4D74-9C16-64C5146A5A40</gtr:id><gtr:firstName>Pitt</gtr:firstName><gtr:otherNames>O</gtr:otherNames><gtr:surname>Lim</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/96E4EC24-297C-49CB-A78C-6A1A75BE5AA3"><gtr:id>96E4EC24-297C-49CB-A78C-6A1A75BE5AA3</gtr:id><gtr:firstName>Dana</gtr:firstName><gtr:surname>Dawson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5039D65A-4724-47A1-B237-A67A599B29CE"><gtr:id>5039D65A-4724-47A1-B237-A67A599B29CE</gtr:id><gtr:firstName>Graeme</gtr:firstName><gtr:surname>MacLennan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E38ECB44-BCD9-4F43-9234-C1A746EA6133"><gtr:id>E38ECB44-BCD9-4F43-9234-C1A746EA6133</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Frenneaux</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2EE29428-9B8F-4235-8FC1-798ADE26276F"><gtr:id>2EE29428-9B8F-4235-8FC1-798ADE26276F</gtr:id><gtr:firstName>Juan-Carlos</gtr:firstName><gtr:surname>Kaski</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C6B755C2-2C91-4B0D-8704-56A985EBC072"><gtr:id>C6B755C2-2C91-4B0D-8704-56A985EBC072</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:surname>Redpath</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/40D6088C-0CEE-4BD5-A0F3-0F81B0899793"><gtr:id>40D6088C-0CEE-4BD5-A0F3-0F81B0899793</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:surname>Cook</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9517B02-8FC8-4D1A-AAC2-34190B1F85FA"><gtr:id>C9517B02-8FC8-4D1A-AAC2-34190B1F85FA</gtr:id><gtr:firstName>Melanie</gtr:firstName><gtr:surname>Madhani</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001340"><gtr:id>A9AD61D9-7A41-429A-BA76-C3DBF0E7C4C7</gtr:id><gtr:title>Does nitrite reduce ischaemia-reperfusion injury in patients with acute ST segment elevation myocardial infarction?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001340</gtr:grantReference><gtr:abstractText>Heart attacks are common and are due to a blockage of one of the arteries that supply the heart with blood. The associated lack of oxygen supply causes death of the heart muscle supplied by this artery. Prompt opening of the blocked artery (eg by inflation of a balloon in the artery) limits the extent of this damage. However, the restoration of blood flow itself causes a degree of damage to the heart muscle. In this study we plan to investigate whether a drug called sodium nitrite given to patients suffering from heart attacks immediately before opening the blocked artery will reduce the damage to the heart muscle. This is important because when a large amount of heart muscle is damaged the patient is at risk of developing heart failure a condition associated with breathlessness and a poor survival.</gtr:abstractText><gtr:technicalSummary>The anion nitrite is reduced to nitric oxide under hypoxic and/or acidotic conditions, resulting in targeted delivery of nitric oxide to hypoxic tissues. Recent work in animal models has shown that nitrite administration at doses well below those which have any effect on blood pressure potently protects against ischaemia- reperfusion injury when administered either before ischaemia or immediately before reperfusion. This proposal will evaluate whether nitrite administration protects against ischaemia-reperfusion injury and reduces infarct size in patients presenting with acute ST segment elevation myocardial infarction.</gtr:technicalSummary><gtr:fund><gtr:end>2014-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1234098</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6543920E-E166-4E47-A575-8BAA8A553042</gtr:id><gtr:title>Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials.</gtr:title><gtr:parentPublicationTitle>International journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c10c36e01bb69f70a75d9c836510f02d"><gtr:id>c10c36e01bb69f70a75d9c836510f02d</gtr:id><gtr:otherNames>Campo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0167-5273</gtr:issn><gtr:outcomeId>5aaa7402bc0bd8.53386060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAB04A94-7A02-4F75-A798-5ADE21A84454</gtr:id><gtr:title>Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/756801284f692aea56448b3d02451f18"><gtr:id>756801284f692aea56448b3d02451f18</gtr:id><gtr:otherNames>Dyson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5a36131c9e7175.92972050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>232DCC60-FA5A-40A9-BEED-41A396DCAEE5</gtr:id><gtr:title>Selection of magnetization catalyzation and readout methods for modified Look-Locker inversion recovery: a T1 mapping primer.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa1f9d95237453e31d6e55d51822faf2"><gtr:id>fa1f9d95237453e31d6e55d51822faf2</gtr:id><gtr:otherNames>Cameron D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0730-725X</gtr:issn><gtr:outcomeId>56d6cb5f606212.55159743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96C8C87C-89EC-4B78-B98F-DF035D83D46A</gtr:id><gtr:title>T1 mapping for assessment of myocardial injury and microvascular obstruction at one week post myocardial infarction.</gtr:title><gtr:parentPublicationTitle>European journal of radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa1f9d95237453e31d6e55d51822faf2"><gtr:id>fa1f9d95237453e31d6e55d51822faf2</gtr:id><gtr:otherNames>Cameron D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0720-048X</gtr:issn><gtr:outcomeId>56d6cb5ed9ead5.28487100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD5141EB-B2DC-43A8-9905-C56059266A37</gtr:id><gtr:title>Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention.</gtr:title><gtr:parentPublicationTitle>Data in brief</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c10c36e01bb69f70a75d9c836510f02d"><gtr:id>c10c36e01bb69f70a75d9c836510f02d</gtr:id><gtr:otherNames>Campo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2352-3409</gtr:issn><gtr:outcomeId>5aaa73d75137e9.62517634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B35E8AF1-F5E9-40E6-B304-C1D7C1476CAA</gtr:id><gtr:title>Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI).</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c01fe5b049ea54b4624f6ad5f5ed8fa7"><gtr:id>c01fe5b049ea54b4624f6ad5f5ed8fa7</gtr:id><gtr:otherNames>Siddiqi N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>545cfa64d453c4.65404466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FE5C1CE-B957-43C4-AC3E-80B4526AB173</gtr:id><gtr:title>Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI).</gtr:title><gtr:parentPublicationTitle>Journal of translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c01fe5b049ea54b4624f6ad5f5ed8fa7"><gtr:id>c01fe5b049ea54b4624f6ad5f5ed8fa7</gtr:id><gtr:otherNames>Siddiqi N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1479-5876</gtr:issn><gtr:outcomeId>DqsAHjfHJus</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001340</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>